Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-TYMS Antibody (R1J75)

Catalog #:   RHC10801 Specific References (28) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IF, IHC, IP, WB
Accession: P04818
Overview

Catalog No.

RHC10801

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IHC: 1:50-1:100, IP: 1:20, WB: 1:500-1:1000

Target

TS, Thymidylate synthase, TSase, TYMS

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P04818

Applications

IF, IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1J75

Data Image
  • Immunofluorescence
    Immunocytochemistry analysis of Thymidylate Synthase (green) in Jurkat using Thymidylate Synthase antibody,and DAPI(blue).
  • Immunohistochemical
    Immunohistochemistry analysis of paraffin-embedded Human tonsil using Thymidylate Synthase antibody. High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
  • Western blot
    Western blot analysis of Thymidylate Synthase in K562 lysates using Thymidylate Synthase antibody.
References

A Rare Case of a Malignant Proliferating Trichilemmal Tumor: A Molecular Study Harboring Potential Therapeutic Significance and a Review of Literature., PMID:39727620

Multiplexed immunoassay for a serum autoantibody biomarker panel in diagnostic and prognostic prediction of canine mammary tumors., PMID:39639821

Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer., PMID:39576003

Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer., PMID:33931971

Functional differences and similarities in activated peripheral blood mononuclear cells by lipopolysaccharide or phytohemagglutinin stimulation between human and cynomolgus monkeys., PMID:33708884

Significant association of serum autoantibodies to TYMS, HAPLN1 and IGFBP5 with early stage canine malignant mammary tumours., PMID:33038064

Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancer., PMID:32847480

ASCO 2016 - update colorectal liver metastases., PMID:28725278

Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients., PMID:27068564

Application of Various Statistical Models to Explore Gene-Gene Interactions in Folate, Xenobiotic, Toll-Like Receptor and STAT4 Pathways that Modulate Susceptibility to Systemic Lupus Erythematosus., PMID:26689915

Immunohistochemical features associated with sensitivity to lapatinib-plus-capecitabine and resistance to trastuzumab in HER2-positive breast cancer., PMID:25075058

Epigenetic modulation of RFC1, MHC2TA and HLA-DR in systemic lupus erythematosus: association with serological markers and six functional polymorphisms of one-carbon metabolic pathway., PMID:24333266

Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan., PMID:22486600

Antitumour activity of S-1 in combination with cetuximab on human gastric cancer cell lines in vivo., PMID:22110188

Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab., PMID:22044939

ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors., PMID:21212384

Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer., PMID:21048041

Predictors for remission in rheumatoid arthritis patients: A systematic review., PMID:20235210

Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy., PMID:16055198

Nuclear expression of thymidylate synthase in colorectal cancer cell lines and clinical samples., PMID:15956025

Treatment with the alpha-glucosidase 1 inhibitor 6-O-butanoyl castanospermine reduces the detection of LFA-1 (CD18/CD11a) by monoclonal antibodies., PMID:7780199

Specific interaction of 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid with human cellular CD4., PMID:7954838

The prevention of cell adhesion and the cell-to-cell spread of HIV-1 in vitro by the alpha-glucosidase 1 inhibitor, 6-O-butanoyl castanospermine (MDL 28574)., PMID:7847878

Stilbene disulfonic acids. CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle., PMID:2071607

Ultrastructural changes and immunocytochemical analysis of human placental trophoblast during short-term culture., PMID:2660124

Loss of cytomegalovirus infectivity after treatment with castanospermine or related plant alkaloids correlates with aberrant glycoprotein synthesis., PMID:2852915

Cellular polypeptides overexpressed after herpes simplex infection permit virus subtyping and may help diagnose cervical cancer., PMID:2849592

Modification of the fluorescing cell assay method for human cytomegalovirus (HCMV)., PMID:212658

Datasheet

Document Download

Anti-TYMS Antibody (R1J75).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-TYMS Antibody (R1J75) [RHC10801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only